AG
QGENF

Aperio Group’s QIAGEN NV QGENF Stock Holding History

Aperio Group’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-165,076
Closed -$4.63M – 2222
2016
Q4 		$4.63M Sell
165,076
-19,890
-11% -$557K 0.04% 530
2016
Q3 		$5.08M Buy
184,966
+21,973
+13% +$603K 0.04% 531
2016
Q2 		$3.56M Sell
162,993
-94,766
-37% -$2.07M 0.03% 623
2016
Q1 		$5.76M Buy
257,759
+5,132
+2% +$115K 0.05% 424
2015
Q4 		$6.99M Buy
252,627
+15,896
+7% +$440K 0.06% 344
2015
Q3 		$6.11M Buy
236,731
+18,130
+8% +$468K 0.06% 369
2015
Q2 		$5.42M Buy
218,601
+23,825
+12% +$591K 0.06% 394
2015
Q1 		$4.91M Buy
194,776
+27,185
+16% +$685K 0.06% 410
2014
Q4 		$3.93M Sell
167,591
-21,241
-11% -$498K 0.05% 451
2014
Q3 		$4.3M Buy
188,832
+37,162
+25% +$846K 0.06% 390
2014
Q2 		$3.71M Sell
151,670
-1,746
-1% -$42.7K 0.05% 416
2014
Q1 		$3.24M Buy
+153,416
New +$3.24M 0.05% 522
2013
Q4 		– Sell
-88,757
Closed -$1.9M – 465
2013
Q3 		$1.9M Buy
88,757
+12,743
+17% +$273K 0.04% 608
2013
Q2 		$1.51M Buy
+76,014
New +$1.51M 0.04% 602

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Aperio Group's QGENF Position: Q1 2017 in Review

Aperio Group sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 165,076 shares — an estimated $4.63M sold.

Aperio Group first reported a position in QGENF in Q2 2013 and held it in 14 quarters. The position peaked at $6.99M in Q4 2015. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Aperio Group reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Aperio Group sold 165,076 QIAGEN NV shares in Q1 2017, an estimated $4.63M.
  • Aperio Group first reported a position in QIAGEN NV in Q2 2013 and held it in 14 quarters.
  • Aperio Group's QIAGEN NV position peaked at $6.99M in Q4 2015.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Aperio Group's 13F filing for Q1 2017, filed 5 May 2017.